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Abstract
Background: THP-1 is a human monocytic leukemia cell line derived from a patient with acute
monocytic leukemia. The cell line differentiates into macrophage-like cells by stimulation with
phorbol myristate acetate (PMA). Although it has been used frequently as a model for macrophage
differentiation in research including the FANTOM4/Genome Network Project, there are few
reports on its genomic constitution. Therefore, we attempted to reveal the genomic aberrations
in these cells with the microarray-based comparative genomic hybridization (aCGH) technique.
Findings: We report large aberrations, including deletions 6p, 12p, 17p, and trisomy 8, and
revealed breakpoints in the MLL and MLLT3 genes. Moreover, we found novel genomic aberrations
such as a hemizygous narrow deletion partially containing the TP73  gene and homozygous
deletions, including the CDKN2A, CDKN2B and PTEN genes.
Conclusion: In this study, we identified 119 aberrant regions in autosomal chromosomes, and at
least 16 of these aberrations were less than 100 kb, most of which were undetectable in the
previous works. We also revealed a total of 4.6 Mb of homozygous deleted regions. Our results
will provide a base to precisely understand studies involving the THP-1 cell line, especially the huge
amount of data generated from the FANTOM4/Genome Network Project.
Introduction
As models for the study of myeloid differentiation and
hematopoietic cell differentiation, several human leuke-
mia cell lines are available [1]. Although these myeloid
leukemia cell lines are blocked at certain steps in the mat-
uration and differentiation process, they can be induced
to differentiate into macrophage-like cells by several stim-
uli [1,2].
THP-1 is a human monocytic leukemia cell line that was
cultured from the blood of a 1-year-old male with acute
monocytic leukemia [3]. On stimulation with phorbol
12-myristate 13-acetate (PMA), THP-1 cells cease prolifer-
ation, become adherent, and differentiate into macro-
phage-like cells. They resemble native monocyte-derived
macrophages with respect to numerous criteria [4,5]. In
comparison with other human myeloid cell lines such as
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HL-60, U937, KG-1 or HEL cells, differentiated THP-1
cells behave more like native monocyte-derived macro-
phages [5]. Because of these characteristics, the THP-1 cell
line is a valuable model for studying the mechanisms
involved in macrophage differentiation. Therefore, THP-1
has been used not only as a clinical model of a leukemic
cell, but also as a scientific model of differentiation in
response to various stimuli.
Chromosome rearrangements are commonly associated
with multiple disease states such as cancer. The identifica-
tion and analysis of these genomic rearrangements have
been fundamental for the advancement of research in
these diseases. Cell lines are mostly established from such
disordered tissues, and in the case of some cultured cells,
their genomic constitutions and characteristics continu-
ously alter through passages. Heterogeneity of cells and its
derivative cell lines along with different characteristics
were also reported in the case of THP-1 [4,6,7]. In the
present study, we adopted microarray-based comparative
genomic hybridization (aCGH) techniques and
attempted to provide a comprehensive and detailed
understanding of the genomic aberrations in THP-1 cells.
Materials and methods
Genomic DNAs
The THP-1 cell line was subcloned by the limiting dilution
technique and 1 clone (#5) was selected for its ability to
differentiate relatively homogeneously in response to
PMA [8]. THP-1 cells were cultured in RPMI, containing
10% fetal bovine serum (FBS), penicillin/streptomycin,
10 mM HEPES, 1 mM sodium pyruvate and 50 μM 2-mer-
captoethanol. Genomic DNA was extracted from 5 × 106
cells according to the manufacturer's instructions with the
illustra GenomicPrep Cells and Tissue DNA Isolation Kit
(GE Healthcare UK Ltd., Buckinghamshire, England) and
quantified spectrophotometrically. Human Genomic
DNA: Female (Promega Corporation, Madison, WI, USA)
was purchased as a reference sample.
Microarray-based CGH Analysis
Oligonucleotide microarray experiment using the Human
Genome CGH Microarray Kit 244A (Agilent Technolo-
gies, Inc., Santa Clara, CA, USA) was conducted according
to manufacturer's protocol (version 5.0). The microarray
used for this study was a 1× 244 K slide format printed
using Agilent's 60-mer SurePrint technology, and it has
236385 biological features. Its probes span both the cod-
ing and noncoding regions for comprehensive genome-
wide representation, and the overall median probe spac-
ing is 8.9 kb (7.4 kb in RefSeq genes). THP-1 and human
female genomic DNA (1 μg each) were labeled with Cy5
and Cy3, respectively. The hybridized and washed array
slide was scanned with an Agilent MicroArray Scanner
G2505A (Agilent Technologies, Inc.) and the obtained
TIFF image data was processed with Agilent Feature
Extraction software (version 9.5.3.1) by the CGH-
v4_95_Feb07 protocol (Agilent Technologies, Inc.).
Extracted data was analyzed with Agilent DNA Analytics
4.0 software (version 4.0.81) (Agilent Technologies, Inc.)
and the Aberration Detection Method 2 (ADM-2) algo-
rithm [9] was used to identify contiguous genomic
regions that corresponded to chromosomal aberrations.
Following parameters were used in this analysis: Thresh-
old of ADM-2: 6.0; Centralization: ON (Threshold: 6.0,
Bin Size: 10); Fuzzy Zero: ON; Aberration Filters: ON
(minProbes = 3 AND minAvgAbsLogRatio = 0.5 AND
maxAberrations = 10000 AND percentPenetrance = 0);
Feature Level Filters: ON (gIsSaturated = true OR rIsSatu-
rated = true OR gIsFeatNonUnifOL = true OR rIsFeatNon-
UnifOL = true). At a minimum, 3 contiguous
suprathreshold probes were required to define a change.
To find an obvious homozygous deletion, aberrant
regions with a signal log ratio of less than -3.0 were
searched. Genomic positions were based on the UCSC
March 2006 human reference sequence (hg18) (NCBI
build 36.1 reference sequence).
Microarray data generated from this study has been
deposited in the Center for Information Biology gene
EXpression database (CIBEX) in DNA Data Bank of Japan
(DDBJ) (CIBEX accession number: CBX82) [10] and is
also available from the Genome Network Platform [11].
Results and discussion
THP-1 cells were established by Tsuchiya et al., and they
were reported to have a diploid (46, XY) chromosome
number by karyotype analysis [3]. It is important to exam-
ine the genomic constitution of these cells in order to
interpret the characteristics of THP-1, but there is little
information on the whole-genome analysis of THP-1
cells. Odero et al. conducted cytogenetic analyses to detect
chromosome changes using G-banding, fluorescence in
situ hybridization (FISH) and spectral karyotyping (SKY)
[6]. They reported that these cells have a near-diploid
karyotype and contain a number of aberrations. The dis-
advantage of their techniques, however, was the low-reso-
lution genomic mapping along the chromosome,
permitting the identification of only large chromosomal
aberrations.
Recently, the microarray-based CGH (aCGH) technique,
in particular, the high-density oligonucleotide array-
based technique, was established for whole-genome aber-
ration analysis, and this increased the mapping resolu-
tion. A high mapping resolution enables precise
definition of aberration boundaries and identification of
small homozygous deletions, pinpointing the possible
locations of tumor-suppressor genes. At present, microar-
ray-based CGH methods focus on detecting copy numberBMC Research Notes 2009, 2:153 http://www.biomedcentral.com/1756-0500/2/153
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changes, but rearrangements, such as balanced transloca-
tions or inversions, are not detected by this method.
Therefore, we adapted an oligonucleotide microarray-
based CGH to detect and map regions of DNA gain and
loss in case of THP-1 cells. The aCGH experiment revealed
119 aberrant regions in autosomal chromosomes con-
taining nested regions (Figure 1) [see Additional file 1].
Hybridization revealed a gain of chromosome Y and loss
of chromosome X in THP-1 cells compared with the refer-
ence human female genome; this is because the THP-1 cell
line was derived from a human male patient. We did not
consider data from the chromosomes X and Y in detail,
but we noted the identification of 2 homozygous dele-
tions in chromosome X, namely, chrX: 41631875–
44807102 and chrX: 153194224–153211806 (Figure 2).
Many genes are located in this region and were probably
lost in the THP-1 cell line.
Odero et al. analyzed THP-1 cells and reported: 49, XY,
+der(1)del(1)(p22p36)t(1;12)(p36;q11),del(6)(p21),+d
el (6)(p21),+8,+der(9)t (9;11)(p22;q23) t(9;11) (q12;
q23),-10,der(11)t(9;11)(p22;q23),del (12)(p11), del
(17)(p11),der (20)ins(20;1)(p12;p22p36) [13]/48,
idem, -del(12)(p11) [7]. We confirmed almost all the
reported aberrations of amplifications and deletions, such
as trisomy 8 and deletions at 6p, 12p, and 17p, but we
didn't find monosomy 10 (Figure 1). Owing to local selec-
tive variations, there will probably be differences in the
individual cell lines used by different investigators. The
differences between individually selected cell lines are
presumably responsible for some of the unique results
obtained. Translocation t(9;11)(p22;q23) is a recurring
chromosomal abnormality in acute myeloid leukemia
(AML) cells involving the fusion of 2 genes, MLL and
MLLT3. The genomic MLL/MLLT3 fusion sequence in
THP-1 cells was also reported [6,12]. Odero et al. reported
duplication of the 3' region of MLL and deletion of the
MLLT3 on the derivative chromosome 9. According to
their results, both MLL and MLLT3 have different copy
numbers between the 5' and 3' regions. Although bal-
anced rearrangements are not detected by aCGH methods,
Chromosomal aberrations detected in the THP-1 cell sample Figure 1
Chromosomal aberrations detected in the THP-1 cell sample. Moving averages of signal log ratio for each chromo-
some (window size = 10 points) are represented as a line plot. Each chromosome is represented on the left. Signal log ratio 
increases to the right and decreases to the left of centerline. Losses and gains identified by the software are represented by the 
shaded region and the vertical line.
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we detected amplification in the 3' region of MLL and
MLLT3. We regarded these as breakpoints in the MLL and
MLLT3 genes, because we identified discontinuous copy
number changes in MLL and MLLT3 (Figure 3(A), (B)).
We attempted to find an obvious homozygous deletion,
because the loss of tumor-suppressor genes is one reason
for immortalization of the cells, and the cells can be effec-
tively characterized by the loss of any other genes. Only 7
regions in all chromosomes were identified, and sum of
the extent of these deletions was 4.6 Mb because most of
the regions had relatively small deletions (Table 1).
Homozygous deletion of the CDKN2A  and  CDKN2B
genes was previously observed in THP-1 cells similar to
that in the case of AML patients [13,14]. Our results con-
firmed the loss of these genes in the homozygous deletion
regions and revealed that the aberration in this region was
due to a 965-kb continuous deletion (Figure 4(A)). Local-
Regional loss on the chromosome X Figure 2
Regional loss on the chromosome X. A loss of signals was detected across chromosome X, because the THP-1 cell line 
derived from a human male patient was compared with the reference human female genome. Two local deletions were also 
found (arrows). Weighted log ratio data appear as a scatter plot. Green points represent subthreshold values. The identified 










Breakpoints on the MLL and MLLT3 genes Figure 3
Breakpoints on the MLL and MLLT3 genes. (A) MLL gene on chromosome 11. (B) MLLT3 gene on chromosome 9. The 
MLL and MLLT3 genes had a breakpoint in their gene regions. Weighted log ratio data appear as a scatter plot. Red points rep-
resent suprathreshold values. The identified aberrant region is plotted as a bar graph shaded in red, and height of each bar cor-
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Regions of homozygous deletion Figure 4
Regions of homozygous deletion. (A) Loss of region containing the CDKN2A and CDKN2B genes. A continuous region con-
taining CDKN2A and CDKN2B on chromosome 9 was deleted. (B) Partial loss in the PTEN gene. PTEN lost a part of its gene 
region. Weighted log ratio data appear as a scatter plot. Green points represent subthreshold values. The identified aberrant 
regions are plotted as a bar graph shaded in red, and the height of each bar corresponds to the average log ratio for that inter-
val. (C) Deleted regions displayed on the UCSC Genome Browser. Black boxes represent the identified aberration Nos. 78 










Table 1: Regions of homozygous deletion in THP-1 cells.
No. Chr Cytoband Position Size (bp) Log2Ratio p-value Genes
23 chr3 q26.1 163997028 – 164101976 104949 -3.817441 3.54E-167
26 chr4 q13.2 69138837 – 69166014 27178 -5.754471 1.76E-28
28 chr4 q34.3–q35.1 182336611 – 182614113 277503 -6.675501 1.35E-175
68 chr9 p21.3 21271776 – 22236965 965190 -5.223190 0 IFNA5, KLHL9, IFNA6, IFNA13, IFNA2, 
IFNA8,
IFNA1, IFNE1, MTAP, CDKN2A, CDKN2B, 
hsa-mir-31
78 chr10 q23.31 89654755 – 89680176 25422 -6.492464 3.11E-67 PTEN
124 chrX p11.4–p11.3 41631875 – 44807102 3175228 -5.087696 0 CASK, MAOA, MAOB, NDP, EFHC2, 
FUNDC1, DUSP21, UTX
140 chrX q28 153194224 – 153211806 17583 -6.345479 5.77E-25 TKTL1
Numbers in the extreme left column correspond with Aberration No. in Additional file 1. Positions were based on the UCSC March 2006 human 
reference sequence (hg18) (NCBI build 36.1 reference sequence).BMC Research Notes 2009, 2:153 http://www.biomedcentral.com/1756-0500/2/153
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ized homozygous deletion in the PTEN gene region was
also newly identified in THP-1 cells (Figure 4(B), (C)).
PTEN gene play roles in tumor suppression and mainte-
nance of genomic stability [15]. Somatic mutations in the
PTEN gene have been identified in a number of cancer cell
lines and cancers. The PTEN gene has been analyzed in a
series of primary acute leukemia and cell lines excluding
the THP-1, and it was revealed that a majority of the cell
lines carried mutations or hemizygous deletions at this
gene locus [16]. Conditional deletion of the Pten gene in
adult mouse hematopoietic cells led to myeloproliferative
disease and leukemia [17]. Analyzing software identified
2 aberrant regions in this gene region, aberration Nos. 78
and 79 [see Additional file 1]. Both deleted regions con-
tained the coding exon of PTEN gene (Figure 4(C)). It is
presumed that some of the characteristics of THP-1 cells
are due to the partial deletion of PTEN gene.
The high-density oligonucleotide aCGH enabled us to
detect more detailed aberrations in comparison with con-
ventional methods. Sixteen aberrations less than 100 kb
were found in the identified aberrant regions [see Addi-
tional file 1]. For example, we could find only 12-kb of
deletion in chr1: 3637672–3650111 containing portions
of the TP73 and KIAA0495 genes (Figure 5). Although
there is little information on KIAA0495, TP73 is known to
be a homologue of the TP53 gene and it is involved in the
regulation of the cell cycle, cell death and development
[18]. The number of TP73 transcripts was high in AML
patient samples as compared with normal cells, and TP73
mRNA and protein were strongly expressed in THP-1 cells
[19]. Furthermore, AML patients increased expression of
the shorter TP73  variants, and a particular variant was
only expressed in leukemia cell lines [20]. Partial deletion
of the TP73 locus in THP-1 cells may affect its expression.
In a similar fashion, the deletion locus of the PTEN gene
described above was also small. As 5 of 7 identified
homozygous deletions were less than 278 kb and 3 were
less than 28 kb (Table 1), we could detect these small dele-
tions using the high-density oligonucleotide aCGH. It is
likely that some of these novel narrow aberrations con-
tribute to the characteristics of THP-1 cells.
The FANTOM4/Genome Network Project used THP-1
cells as the model system to understand the transcrip-
tional network underlying growth arrest and differentia-
tion in mammalian cells. A large amount of data,
including the genome-wide transcription start site (TSS)
and systematic siRNA knockdown of key transcription fac-
tors, was generated in this project [8]. We analyzed the
identical THP-1 clone used in the FANTOM4/Genome
Network Project. The results of this study will provide a
useful base for studies in general cell biology, and they
would help to precisely understand the data generated by
the FANTOM4/Genome Network Project.
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Deletion in the region containing the TP73 gene Figure 5
Deletion in the region containing the TP73 gene. One 
narrow deletion on chromosome 1 included the KIAA0495 
and TP73 genes. Weighted log ratio data appear as a scatter 
plot. Green points represent subthreshold values. The identi-
fied aberrant region is plotted as a bar graph shaded in red, 
and the height of each bar corresponds to the average log 
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